Alberto Garcia-Salido, Fabienne Venet, Jesus F Bermejo-Martin, Ignacio Rubio, Marcin Osuchowski, Tomasz Skirecki, Martin Sebastian Winkler, Manu Shankar-Hari, Jean-Marc Cavaillon, Guillaume Monneret, Antoni Torres, Michael Bauer, Frank M Brunkhorst, Joerg C Schefold, Massimo Girardis, Gunnar Lachmann, Ignacio Martin-Loeches, Stefanie B Flohé, Raquel Almansa Mora, Brendon P Scicluna, Andrea Cossarizza, Evangelos J Giamarellos-Bourboulis, Matthijs Kox, Sara Cajander, Markus A Weigand
Journal: The Lancet. Respiratory medicine 2024;12(4):305-322
PMID: 38142698
Sepsis is characterised by a dysregulated host immune response to infection. Despite recognition of its significance, immune status monitoring is not implemented in clinical practice due in part to the current absence of direct therapeutic implications. Technological advances in immunological profiling could enhance our understanding of immune dysregulation and facilitate integration into clinical practice. In this Review, we provide an overview of the current state of immune profiling in sepsis, including its use, current challenges, and opportunities for progress. We highlight the important role of immunological biomarkers in facilitating predictive enrichment in current and future treatment scenarios. We propose that multiple immune and non-immune-related parameters, including clinical and microbiological data, be integrated into diagnostic and predictive combitypes, with the aid of machine learning and artificial intelligence techniques. These combitypes could form the basis of workable algorithms to guide clinical decisions that make precision medicine in sepsis a reality and improve patient outcomes.
Copyright © 2024 Elsevier Ltd. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.